The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 13, 2014

Filed:

Sep. 01, 2009
Applicants:

Matthew F. Brown, Groton, CT (US);

Charles F. Donovan, Colchester, CT (US);

Edmund L. Ellsworth, Kalamazoo, MI (US);

Denton W. Hoyer, Niantic, CT (US);

Timothy A. Johnson, Richland, MI (US);

Manjinder S. Lall, Groton, CT (US);

Chris Lim-berakis, Groton, CT (US);

Sean T. Murphy, San Diego, CA (US);

Debra A. Sherry, Chelsea, MI (US);

Clarke B. Taylor, Ann Arbor, MI (US);

Joseph S. Warmus, Groton, CT (US);

Inventors:

Matthew F. Brown, Groton, CT (US);

Charles F. Donovan, Colchester, CT (US);

Edmund L. Ellsworth, Kalamazoo, MI (US);

Denton W. Hoyer, Niantic, CT (US);

Timothy A. Johnson, Richland, MI (US);

Manjinder S. Lall, Groton, CT (US);

Chris Lim-Berakis, Groton, CT (US);

Sean T. Murphy, San Diego, CA (US);

Debra A. Sherry, Chelsea, MI (US);

Clarke B. Taylor, Ann Arbor, MI (US);

Joseph S. Warmus, Groton, CT (US);

Assignee:

Pfizer Inc., New York, NY (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/70 (2006.01); A61K 31/67 (2006.01); A61K 31/165 (2006.01); A61K 31/415 (2006.01); A61K 31/535 (2006.01); C07D 239/42 (2006.01); C07D 413/02 (2006.01); C07D 239/02 (2006.01); C07D 491/02 (2006.01); C07D 213/56 (2006.01); C07D 277/30 (2006.01); C07D 261/06 (2006.01); C07D 403/02 (2006.01); C07D 233/54 (2006.01); C07D 307/02 (2006.01); C07D 235/02 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention relates to a compound of formula (I): or a pharmaceutically acceptable salt thereof, thereof, wherein: G is a group of formula (II); and pharmaceutically acceptable salts, prodrugs, hydrates, or solvates, thereof, wherein A, B. L-LA, B, R-Rand m are as defined herein. The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) and their use in treating a bacterial infection.


Find Patent Forward Citations

Loading…